- Home
- MED vs XBIT Comparison
MED vs XBIT Comparison
Compare MED & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- XBIT
- Stock Information
- Founded
- MED 1980
- XBIT 2005
- Country
- MED United States
- XBIT United States
- Employees
- MED N/A
- XBIT N/A
- Industry
- MED Packaged Foods
- XBIT Pharmaceuticals and Biotechnology
- Sector
- MED Consumer Staples
- XBIT Health Care
- Exchange
- MED Nasdaq
- XBIT Nasdaq
- Market Cap
- MED 187.3M
- XBIT 194.5M
- IPO Year
- MED N/A
- XBIT 2015
- Fundamental
- Price
- MED $14.73
- XBIT $2.99
- Analyst Decision
- MED Hold
- XBIT
- Analyst Count
- MED 1
- XBIT 0
- Target Price
- MED $16.50
- XBIT N/A
- AVG Volume (30 Days)
- MED 230.8K
- XBIT 54.9K
- Earning Date
- MED 02-18-2025
- XBIT 03-14-2025
- Dividend Yield
- MED N/A
- XBIT N/A
- EPS Growth
- MED N/A
- XBIT N/A
- EPS
- MED 0.19
- XBIT N/A
- Revenue
- MED $602,463,000.00
- XBIT N/A
- Revenue This Year
- MED N/A
- XBIT N/A
- Revenue Next Year
- MED N/A
- XBIT N/A
- P/E Ratio
- MED $77.53
- XBIT N/A
- Revenue Growth
- MED N/A
- XBIT N/A
- 52 Week Low
- MED $13.57
- XBIT $2.99
- 52 Week High
- MED $42.68
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- MED 39.93
- XBIT 31.96
- Support Level
- MED $13.57
- XBIT $3.03
- Resistance Level
- MED $16.66
- XBIT $3.32
- Average True Range (ATR)
- MED 0.74
- XBIT 0.19
- MACD
- MED -0.02
- XBIT 0.04
- Stochastic Oscillator
- MED 37.54
- XBIT 0.00
About MED MEDIFAST INC
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.